학술논문
The ABCB1/ABCG2 inhibitor elacridar is a more potent pharmaco-enhancer compared to tariquidar for treatment of intracranial tumors with small molecule drugs
Document Type
Journal
Source
Subject
Language
English
ISSN
18790852